Amanote Research

Amanote Research

    RegisterSign In

Vaccination With Syngeneic, Lymphoma-Derived Immunoglobulin Idiotype Combined With Granulocyte/Macrophage Colony-Stimulating Factor Primes Mice for a Protective T-Cell Response.

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.93.20.10972
Full Text
Open PDF
Abstract

Available in full text

Categories
Multidisciplinary
Date

October 1, 1996

Authors
L. W. KwakH. A. YoungR. W. PenningtonS. D. Weeks
Publisher

Proceedings of the National Academy of Sciences


Related search

Clozapine-Associated Agranulocytosis Treatment With Granulocyte Colony-Stimulating Factor/Granulocyte-Macrophage Colony-Stimulating Factor

Journal of Clinical Psychopharmacology
PsychiatryMental HealthPharmacology
2017English

Granulocyte-Macrophage Colony-Stimulating Factor

Reactions Weekly
1994English

Granulocyte-Macrophage Colony-Stimulating Factor

Reactions Weekly
1990English

Granulocyte-Macrophage Colony-Stimulating Factor

Reactions Weekly
1991English

Granulocyte-Macrophage Colony Stimulating Factor

Reactions Weekly
1995English

Granulocyte-Macrophage Colony-Stimulating Factor

Reactions Weekly
1992English

Granulocyte-Macrophage Colony-Stimulating Factor

Reactions Weekly
1991English

Granulocyte-Macrophage Colony-Stimulating Factor

Reactions Weekly
1991English

Cutting Edge: Granulocyte-Macrophage Colony-Stimulating Factor Is the Major CD8+ T Cell-Derived Licensing Factor for Dendritic Cell Activation

Journal of Immunology
AllergyImmunology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy